Barnett, J. C., Bland, A., Whitaker, R., Calingaert, B., Bentley, R. C., Lee, P. S., … Berchuck, A. (2008). The prognostic significance of p53 and cyclin E overexpression in ovarian cancer: A population-based study. GYNECOLOGIC ONCOLOGY, 108(3), S125–S125.

Barnett, J. C., A. Bland, R. Whitaker, B. Calingaert, R. C. Bentley, P. S. Lee, P. C. Moorman, J. M. Schildkraut, and A. Berchuck. “The prognostic significance of p53 and cyclin E overexpression in ovarian cancer: A population-based study.” GYNECOLOGIC ONCOLOGY 108, no. 3 (March 2008): S125–S125.

Barnett JC, Bland A, Whitaker R, Calingaert B, Bentley RC, Lee PS, et al. The prognostic significance of p53 and cyclin E overexpression in ovarian cancer: A population-based study. GYNECOLOGIC ONCOLOGY. 2008 Mar;108(3):S125–S125.

Barnett, J. C., et al. “The prognostic significance of p53 and cyclin E overexpression in ovarian cancer: A population-based study.” GYNECOLOGIC ONCOLOGY, vol. 108, no. 3, Mar. 2008, pp. S125–S125.

Barnett JC, Bland A, Whitaker R, Calingaert B, Bentley RC, Lee PS, Moorman PC, Schildkraut JM, Berchuck A. The prognostic significance of p53 and cyclin E overexpression in ovarian cancer: A population-based study. GYNECOLOGIC ONCOLOGY. 2008 Mar;108(3):S125–S125.